Binex (Busan) Overview
- Year Founded
-
1957
- Status
-
Public
- Employees
-
730
- Stock Symbol
-
053030
- Investments
-
4
- Share Price
-
$4.76
- (As of Thursday Closing)
Binex (Busan) General Information
Description
Binex Co Ltd is engaged in manufacturing and distribution of pharmaceutical products. The key products include gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as an ointment, creams, and others. It also manufactures biomedicines and raw materials. Its other business operation involved contract development and manufacturing business for other companies. The company invests in some bio ventures that develop biomedicines.
Contact Information
Website
www.bi-nex.co.krCorporate Office
- 368-3 Dadae-ro
- Saha-gu
- Busan, 49496
- South Korea
Corporate Office
- 368-3 Dadae-ro
- Saha-gu
- Busan, 49496
- South Korea
Binex (Busan) Stock Performance
As of 12-Nov-2026, Binex (Busan)’s stock price is $4.76. Its current market cap is $152M with 31.8M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.76 | $5.02 | $3.81 - $11.74 | $152M | 31.8M | 91.6K | -$0.63 |
Binex (Busan) Financials Summary
As of 30-Jun-2026, Binex (Busan) has a trailing 12-month revenue of $108M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 205,261 | 384,770 | 426,205 | 238,553 |
| Revenue | 108,378 | 118,383 | 95,314 | 118,417 |
| EBITDA | (7,900) | 8,408 | (18,140) | 11,951 |
| Net Income | (20,166) | (2,267) | (25,704) | 3,572 |
| Total Assets | 202,243 | 216,265 | 189,677 | 199,438 |
| Total Debt | 78,089 | 67,448 | 44,841 | 41,521 |
Binex (Busan) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Binex (Busan) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Binex (Busan) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Binex (Busan) Investments (4)
Binex (Busan)’s most recent deal was a Joint Venture with Manufacturer of Pharmaceuticals (Binex / Zein Pharmaceutical). The deal was made on 01-Sep-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Manufacturer of Pharmaceuticals (Binex / Zein Pharmaceutical) | 01-Sep-2019 | Joint Venture | Pharmaceuticals | ||
| PeproMene Bio | 11-Jun-2018 | Early Stage VC | Drug Discovery | ||
| Hanwha Chemical (Osong Factory) | 01-Sep-2015 | Corporate Asset Purchase | Buildings and Property | ||
| Aprogen | 01-Jan-2012 | Corporate | Biotechnology |
Binex (Busan) ESG
Risk Overview
Risk Rating
Updated September, 30, 2025
36.89 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,766
Rank
Percentile
Pharmaceuticals
Industry
of 891
Rank
Percentile
Pharmaceuticals
Subindustry
of 435
Rank
Percentile
Binex (Busan) Exits (1)
Binex (Busan)’s most recent exit was on 01-Jan-2012 from Aprogen. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Aprogen | 01-Jan-2012 | Completed |
|
Binex (Busan) FAQs
-
When was Binex (Busan) founded?
Binex (Busan) was founded in 1957.
-
Where is Binex (Busan) headquartered?
Binex (Busan) is headquartered in Busan, South Korea.
-
What is the size of Binex (Busan)?
Binex (Busan) has 730 total employees.
-
What industry is Binex (Busan) in?
Binex (Busan)’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Binex (Busan) a private or public company?
Binex (Busan) is a Public company.
-
What is Binex (Busan)’s stock symbol?
The ticker symbol for Binex (Busan) is 053030.
-
What is the current stock price of Binex (Busan)?
As of 12-Nov-2026 the stock price of Binex (Busan) is $4.76.
-
What is the current market cap of Binex (Busan)?
The current market capitalization of Binex (Busan) is $152M.
-
What is Binex (Busan)’s current revenue?
The trailing twelve month revenue for Binex (Busan) is $108M.
-
What is Binex (Busan)’s annual earnings per share (EPS)?
Binex (Busan)’s EPS for 12 months was -$0.63.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
